George Pro

Federal Grant PI

Assistant Professor

Last publication 2026 Last refreshed 2026-05-22

faculty

Health Behavior & Health Education, College of Public Health

gcpro@uams.edu

17 h-index 69 pubs 830 cited

Biography and Research Information

OverviewAI-generated summary

George Pro is an Assistant Professor in Health Behavior & Health Education at the University of Arkansas for Medical Sciences. His research interests include substance use disorders, health disparities, and public health trends in the United States. Pro has investigated national trends in substance use disorder treatment, including shifts in methamphetamine administration routes and factors associated with positive heroin and opioid treatment response.

His work also examines disparities in healthcare access and outcomes. This includes analyses of COVID-19 vaccination rates based on community vulnerability, state-level differences in Spanish-language mental health treatment availability, and the impact of rurality on mask-wearing behaviors during the pandemic. Pro has also studied patterns of physical activity among incarcerated women and the relationship between excessive alcohol use, rurality, and COVID-19 case fatality rates.

Pro is a federally funded principal investigator, having received $226,693 from the NIH/National Institute on Drug Abuse for the validation of a survey tool to evaluate patient-reported outcomes for new medications to treat methamphetamine use disorder. He leads a research group and maintains an active lab website. Pro has a publication record of 66 articles, with an h-index of 17 and over 800 citations, and collaborates with researchers from institutions including the University of Arkansas for Medical Sciences and the University of Arkansas for Fayetteville.

Metrics

  • h-index: 17
  • Publications: 69
  • Citations: 830

Selected Publications

  • Social determinants of health associated with human papillomavirus vaccine uptake among teens (2026)
  • Co-occurring substance use disorders and the compounding effect of kratom on serious mental illness, US, 2021–2023 (2026)
  • Rising and disparate trends in the private/for-profit acquisition of nonprofit substance use treatment facilities, US, 2019–2024 (2026)
  • From kratom to 7-hydroxymitragynine: evolution of a natural remedy into a public-health threat (2025)
    1 citation DOI OpenAlex
  • Geographic and Policy Factors Influence Telehealth Availability for Substance Use Disorder Treatment (2025)
  • Differential Associations Between Increasing Opioid Withdrawal Symptoms and More Frequent Methamphetamine Use, US, 2022–2023 (2025)
  • Place-based access to integrated mental health services within substance use disorder treatment facilities in the US (2025)
    1 citation DOI OpenAlex
  • Association between different modalities of opioid use disorder-related care delivery and opioid use disorder-related patient outcomes: A retrospective cohort study (2025)
  • Services Provided in Spanish in Substance Use Disorder Treatment Facilities: Limited Access in Communities with Fast-Growing Spanish-Speaking Populations (2024)
    1 citation DOI OpenAlex
  • Setting factors associated with licensed psychotherapists’ interest in the implementation of electroencephalogram neurofeedback into practice. (2024)
    1 citation DOI OpenAlex
  • Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge (2024)
    1 citation DOI OpenAlex
  • Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study (2024)
    1 citation DOI OpenAlex
  • A multilevel analysis of changing telehealth availability in opioid use disorder treatment settings: Conditional effects of rurality, the number and types of medication for opioid use disorder available, and time, US, 2016–2023 (2024)
    1 citation DOI OpenAlex
  • Geographic and Racial/Ethnic Differences in Access to Methamphetamine Detoxification Services, United States, 2021 (2024)
    4 citations DOI OpenAlex
  • Factors Associated With Self-Reported Overdose Reversals Using Naloxone in Little Rock, Arkansas: Implications for Harm Reduction Service Delivery in the US South (2024)

View all publications on OpenAlex →

Federal Grants 1 $226,693 total

NIH/National Institute on Drug Abuse Contact PI Sep 2024 - Aug 2026

Validation of a survey tool to evaluate patient-reported outcomes for new medications to treat methamphetamine use disorder: The PROMT Survey

National Institute on Drug Abuse $226,693 R21

Grants & Funding

  • Linking Criminal Justice and Health Data: Challenges and Opportunities Robert Wood Johnson Foundation Principal Investigator
  • Validation of a survey tool to evaluate patient-reported outcomes for new medications to treat methamphetamine use disorder: The PROMT Survey NIH/Nat. Inst. on Drug Abuse Principal Investigator
  • Validation of a survey tool to evaluate patient-reported outcomes for new medications to treat methamphetamine use disorder: The PROMT Survey NIH/Nat. Inst. on Drug Abuse Principal Investigator
  • Validation of a survey tool to evaluate patient-reported outcomes for new medications to treat methamphetamine use disorder: The PROMT Survey NIH/Nat. Inst. on Drug Abuse Principal Investigator

Collaboration Network

123 Collaborators 31 Institutions 4 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics